Skip to main content Accessibility help
×
Home
Hostname: page-component-564cf476b6-2fphr Total loading time: 0.213 Render date: 2021-06-22T21:16:40.194Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

Published online by Cambridge University Press:  20 November 2013

Kathryn A. Ellis
Affiliation:
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia National Ageing Research Institute (NARI), Parkville, Victoria, Australia
Cassandra Szoeke
Affiliation:
National Ageing Research Institute (NARI), Parkville, Victoria, Australia Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Ashley I. Bush
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
David Darby
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Petra L. Graham
Affiliation:
Macquarie University, Sydney, NSW, Australia
Nicola T. Lautenschlager
Affiliation:
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia School of Psychiatry and Clinical Neurosciences and WA Centre for Health and Ageing, University of Western Australia, Crawley, WA, Australia
S. Lance Macaulay
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Ralph N. Martins
Affiliation:
Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia
Paul Maruff
Affiliation:
CogState Limited, Melbourne, Victoria, Australia
Colin L. Masters
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Simon J. McBride
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Kerryn E. Pike
Affiliation:
Latrobe University, Melbourne, Victoria, Australia
Stephanie R. Rainey-Smith
Affiliation:
Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia
Alan Rembach
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Joanne Robertson
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Christopher C. Rowe
Affiliation:
Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, University of Melbourne; Austin Health, Heidelberg, Victoria, Australia
Greg Savage
Affiliation:
Macquarie University, Sydney, NSW, Australia
Victor L. Villemagne
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
Michael Woodward
Affiliation:
Austin Health, Aged Care, Heidelberg, Victoria, Australia
William Wilson
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Ping Zhang
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
David Ames
Affiliation:
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia National Ageing Research Institute (NARI), Parkville, Victoria, Australia
Corresponding
E-mail address:

Abstract

Background:

The Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing is a prospective study of 1,112 individuals (211 with Alzheimer's disease (AD), 133 with mild cognitive impairment (MCI), and 768 healthy controls (HCs)). Here we report diagnostic and cognitive findings at the first (18-month) follow-up of the cohort. The first aim was to compute rates of transition from HC to MCI, and MCI to AD. The second aim was to characterize the cognitive profiles of individuals who transitioned to a more severe disease stage compared with those who did not.

Methods:

Eighteen months after baseline, participants underwent comprehensive cognitive testing and diagnostic review, provided an 80 ml blood sample, and completed health and lifestyle questionnaires. A subgroup also underwent amyloid PET and MRI neuroimaging.

Results:

The diagnostic status of 89.9% of the cohorts was determined (972 were reassessed, 28 had died, and 112 did not return for reassessment). The 18-month cohort comprised 692 HCs, 82 MCI cases, 197 AD patients, and one Parkinson's disease dementia case. The transition rate from HC to MCI was 2.5%, and cognitive decline in HCs who transitioned to MCI was greatest in memory and naming domains compared to HCs who remained stable. The transition rate from MCI to AD was 30.5%.

Conclusion:

There was a high retention rate after 18 months. Rates of transition from healthy aging to MCI, and MCI to AD, were consistent with established estimates. Follow-up of this cohort over longer periods will elucidate robust predictors of future cognitive decline.

Type
Research Article
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below.

References

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Health Disorders, 4th edn. Washington, DC: American Psychiatric Association.Google ScholarPubMed
Buckley, R. et al. (2013). Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: a cross-sectional analysis. International Psychogeriatrics, 7, S239.Google Scholar
Craig, C. L. et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 13811395.CrossRefGoogle ScholarPubMed
Delis, D., Kramer, J., Kaplan, E. and Ober, B. (2000). California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation.Google Scholar
Delis, D. C., Kaplan, E. and Kramer, J. H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio, TX: The Psychological Corporation.Google Scholar
Ellis, K. A. et al. (2009). The Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672687.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.CrossRefGoogle ScholarPubMed
Jorm, A. F. and Jacomb, P. A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 10151022.CrossRefGoogle ScholarPubMed
Kurz, A. and Lautenschlager, N. L. (2010). Established treatements for Alzheimer's disease: cholinesterase inhibitors and memantine. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 471483). London: Hodder.Google ScholarPubMed
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.CrossRefGoogle ScholarPubMed
Mewton, L., Sachdev, P., Anderson, T., Sunderland, M. and Andrews, G. (2013). Demographic, clinical, and lifestyle correlates of subjective memory complaints in the Australian population. American Journal of Geriatric Psychiatry, doi: 10.1016/j.jagp.2013.04.004.Google ScholarPubMed
Meyers, J. E. and Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial: Professional Manual. Lutz, FL: Psychological Assessment Resource, Inc. Google Scholar
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.CrossRefGoogle ScholarPubMed
Morris, J. C. et al. (2012). Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clinical Investigation (London), 2, 975984.CrossRefGoogle ScholarPubMed
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303308.CrossRefGoogle ScholarPubMed
Reiman, E. M. et al. (2011). Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. Journal of Alzheimer's Disease, 26, 321329.Google ScholarPubMed
Rowe, C. C. et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Imaging beta-amyloid burden in aging and dementia. Neurobiology of Aging, 31, 12751283.CrossRefGoogle Scholar
Savage, G. (2010). Neuropsychological assessment of dementia. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 6167). London: Hodder.Google ScholarPubMed
Saxton, J. et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526534.CrossRefGoogle ScholarPubMed
Schneider, L. S., Insel, P. S., Weiner, M. W. and the Alzheimer's Disease Neuroimaging Initiative (2011). Treatment with cholinesterase inhibitors and memantine in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 5866.CrossRefGoogle ScholarPubMed
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Clinical Gerontology: Guide to Assessment and Intervention (pp. 165173). New York: The Haworth Press.Google Scholar
Slavin, M. J. et al. (2010). Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. American Journal of Geriatric Psychiatry, 18, 701710.CrossRefGoogle ScholarPubMed
Snaith, R. P. and Zigmond, A. S. (1986). The hospital anxiety and depression scale. British Medical Journal (Clinical Research Ed.), 292, 344.CrossRefGoogle ScholarPubMed
Sona, A. et al. (2012). Predictors of rapid decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. International Psychogeriatrics, 24, 197204.CrossRefGoogle ScholarPubMed
Sperling, R. A. et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers & Dementia, 7, 280292.CrossRefGoogle ScholarPubMed
Strauss, E., Sherman, E. M. S. and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edn. New York: Oxford University Press.Google Scholar
Wechsler, D. (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 8795.CrossRefGoogle Scholar
Wechsler, D. (1997). Wechsler Adult Intelligence Scale–Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.Google Scholar
Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, Texas: The Psychological Corporation.Google Scholar
Winblad, B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240246.CrossRefGoogle Scholar
World Health Organization (1992). ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.Google ScholarPubMed
Zigmond, A. S. and Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361370.CrossRefGoogle ScholarPubMed
25
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *